Myeloid Neoplasia: A Review of Clinical Features and Diagnostic Criteria. Part 2: The Myeloproliferative Neoplasms (May 29, 2022 - May 28, 2025)
hosted byOpus Medicus, Inc.Myeloid Neoplasia: A Review of Clinical Features and Diagnostic Criteria. Part 2: The Myeloproliferative Neoplasms is organized by Opus Medicus, Inc.
Course Dates:
Last Review Date: 29-May-2022
Expiration Date: 28-May-2025
Description:
This course is part 2 of a 3-part series that details the diagnostic criteria and clinicopathologic features of the myelodysplastic syndromes (part 1), the myeloproliferative neoplasms (part 2), and the acute myeloid leukemias (part 3)
Objectives:
• To compare and contrast the general features of MDS, MPD, and AML
• To delineate the specific diagnostic criteria for all WHO-recognized MDS, MPD, and AML subtypes, including clinical, histologic, immunophenotypic, and genetic features.
Topics:
• Myeloproliferative Neoplasms General Features
• Chronic myelogenous leukemia
• Chronic myelogenous leukemia - Accelerated Phase
• Chronic neutrophilic leukemia
• Polycythemia vera
• Post-PV myelofibrosis
• Primary myelofibrosis
• Essential thrombocythemia
• Post-ET Myelofibrosis
• Chronic eosinophilic leukemia, NOS
• Mastocytosis
• Mast cell leukemia, mast cell sarcoma, and extracutaneous mastocytoma
• Myeloproliferative neoplasm, unclassifiable
